Literature DB >> 9453650

Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon.

R E Tascon1, E Stavropoulos, K V Lukacs, M J Colston.   

Abstract

The role of CD8 T cells in controlling Mycobacterium tuberculosis infections in mice was confirmed by comparing the levels of growth of the organism in control, major histocompatibility complex class II knockout, and athymic mice and by transferring T-cell populations into athymic mice. By using donor mice which were incapable of making gamma interferon (IFN-gamma), it was shown that IFN-gamma production was essential for CD8 cell mediation of protective immunity against M. tuberculosis.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9453650      PMCID： PMC107978     

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  32 in total

1.  Protective role for CD8 cells in tuberculosis.

Authors:  G H Bothamley; F Festenstein; A Newland
Journal:  Lancet       Date:  1992-02-01       Impact factor: 79.321

2.  T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens.

Authors:  I M Orme; E S Miller; A D Roberts; S K Furney; J P Griffin; K M Dobos; D Chi; B Rivoire; P J Brennan
Journal:  J Immunol       Date:  1992-01-01       Impact factor: 5.422

3.  Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients.

Authors:  B Kaleab; T Ottenoff; P Converse; E Halapi; G Tadesse; M Rottenberg; R Kiessling
Journal:  Eur J Immunol       Date:  1990-12       Impact factor: 5.532

4.  The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis.

Authors:  I M Orme
Journal:  J Immunol       Date:  1987-01-01       Impact factor: 5.422

Review 5.  Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse.

Authors:  G J Bancroft; R D Schreiber; E R Unanue
Journal:  Immunol Rev       Date:  1991-12       Impact factor: 12.988

6.  Differential effects of cytolytic T cell subsets on intracellular infection.

Authors:  S Stenger; R J Mazzaccaro; K Uyemura; S Cho; P F Barnes; J P Rosat; A Sette; M B Brenner; S A Porcelli; B R Bloom; R L Modlin
Journal:  Science       Date:  1997-06-13       Impact factor: 47.728

7.  Importance of thymus-derived lymphocytes in cell-mediated immunity to infection.

Authors:  R J North
Journal:  Cell Immunol       Date:  1973-04       Impact factor: 4.868

8.  Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells.

Authors:  I Müller; S P Cobbold; H Waldmann; S H Kaufmann
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

Review 9.  Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis.

Authors:  P C Hopewell
Journal:  Clin Infect Dis       Date:  1992-09       Impact factor: 9.079

10.  Mice lacking MHC class II molecules.

Authors:  D Cosgrove; D Gray; A Dierich; J Kaufman; M Lemeur; C Benoist; D Mathis
Journal:  Cell       Date:  1991-09-06       Impact factor: 41.582
View more
  75 in total

1.  CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection.

Authors:  Aras Kadioglu; William Coward; M Joseph Colston; Colin R A Hewitt; Peter W Andrew
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

2.  Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta.

Authors:  C Manca; L Tsenova; A Bergtold; S Freeman; M Tovey; J M Musser; C E Barry; V H Freedman; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

3.  Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccine.

Authors:  Xindong Teng; Maopeng Tian; Jianrong Li; Songwei Tan; Xuefeng Yuan; Qi Yu; Yukai Jing; Zhiping Zhang; Tingting Yue; Lei Zhou; Xionglin Fan
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Evaluation of a recombinant BCG expressing antigen Ag85B and PPE protein Rv3425 from DNA segment RD11 of Mycobacterium tuberculosis in C57BL/6 mice.

Authors:  Jiu ling Wang; Ya qing Qie; Bing dong Zhu; Hong mei Zhang; Ying Xu; Qing zhong Wang; Jia zhen Chen; Wei Liu; Hong hai Wang
Journal:  Med Microbiol Immunol       Date:  2008-05-20       Impact factor: 3.402

5.  38 000 MW antigen-specific major histocompatibility complex class I restricted interferon-gamma-secreting CD8+ T cells in healthy contacts of tuberculosis.

Authors:  R J Wilkinson; X Zhu; K A Wilkinson; A Lalvani; J Ivanyi; G Pasvol; H M Vordermeier
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

6.  Multivalent TB vaccines targeting the esx gene family generate potent and broad cell-mediated immune responses superior to BCG.

Authors:  Daniel O Villarreal; Jewell Walters; Dominick J Laddy; Jian Yan; David B Weiner
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

7.  Fate of Mycobacterium tuberculosis within murine dendritic cells.

Authors:  K A Bodnar; N V Serbina; J L Flynn
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 8.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Authors:  Joshua S M Woodworth; Samuel M Behar
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

9.  Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in vivo.

Authors:  Joshua S Woodworth; Ying Wu; Samuel M Behar
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

10.  CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination.

Authors:  Tara Elvang; Jan P Christensen; Rolf Billeskov; Truc Thi Kim Thanh Hoang; Peter Holst; Allan Randrup Thomsen; Peter Andersen; Jes Dietrich
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.